APA (7th ed.) Citation

Modest, D., Denecke, T., Pratschke, J., Ricard, I., Lang, H., Bemelmans, M., . . . Neumann, U. (2018). Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer—central evaluation of FIRE-3. European Journal of Cancer, 88, 77. https://doi.org/10.1016/j.ejca.2017.10.028

Chicago Style (17th ed.) Citation

Modest, D.P, et al. "Surgical Treatment Options Following Chemotherapy Plus Cetuximab or Bevacizumab in Metastatic Colorectal Cancer—central Evaluation of FIRE-3." European Journal of Cancer 88 (2018): 77. https://doi.org/10.1016/j.ejca.2017.10.028.

MLA (9th ed.) Citation

Modest, D.P, et al. "Surgical Treatment Options Following Chemotherapy Plus Cetuximab or Bevacizumab in Metastatic Colorectal Cancer—central Evaluation of FIRE-3." European Journal of Cancer, vol. 88, 2018, p. 77, https://doi.org/10.1016/j.ejca.2017.10.028.